AGN has BEST KOLs from Fibrosis/Cough UniverseWhile we await for COVID NP120 interim data for 3rd week of Dec. I just want to highlight that AGN has been successful to include 2 of the best key opinion leaders of Fibrosis and Cough universe in its Scientific Advisory Board.
1) Martin Kolb at McMaster - https://healthsci.mcmaster.ca/firh/physician-details/kolb-martin
He was Canada head for running both Nintadinib and Perfenidone Fibrosis trials and considered to be the best of the best. He is both active as Physician/Clinician and basic science reseacrch lab and always looking for new approaches for Idiopathic Lung Fibrosis (IPF).
https://algernonpharmaceuticals.com/dr-martin-kolb/
2) Jacky Smith - https://www.research.manchester.ac.uk/portal/jacky.smith.html
Similar to Fibrosis, where the KOLs are very concentrated and are very few in nos, Cough space is also very much concentrated to few institutes. Jacky Smith has run all the Cough trials you can imagine in the past. She was Principle Investigator for both Bellus and Merck Cough studies. She was the inventor behind cough measurement system which patients put on during 12 weeks of cough trial.
https://www.globenewswire.com/news-release/2020/02/07/1981672/0/en/Algernon-Pharmaceuticals-Appoints-Professor-of-Respiratory-Medicine-Dr-Jacky-Smith-to-Its-Medical-and-Scientific-Advisory-Board.html
I have had a chance to meet both in the past and are bright personalities. They wont easily associate their name with companies in which they dont believe. I guess its a testament on NP 120 relevance and legitamcy of AGN existence.